Stephen Eason

Stephen is an independent consultant with a successful record in innovation and the development of technologies and teams. He founded Vectura Delivery Devices in 2002 and was a member of Vectura’s Executive Leadership Team until 2016 with responsibility for technology and IP. He led the invention and development of the core device technology used in a range of inhalers including GyroHaler, now approved and marketed in over 30 countries as Sandoz’s AirFluSal Forspiro.
From 1987 to 2002 Stephen worked for Cambridge Consultants Limited (CCL). Whilst at CCL he set up and led CCL’s Drug Delivery Devices Group, which carried out significant product developments in the areas of inhalation, injection and infusion products. Before specialising in drug delivery, Stephen managed a number of healthcare, telecoms and consumer product developments for clients in Europe and the US. Prior to joining CCL Stephen worked in design and development for Baxter Healthcare. He studied Mechanical Engineering at Imperial College.